Is Benzophenone-3 (Oxybenzone) safe in cosmetics?
Benzophenone-3 (Oxybenzone) has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Also known as: BRN 1913145, EINECS 205-031-5, NCI-C60957, NSC-7778, Oxibenzonum (+3 more)
INCI: BENZOPHENONE-3
Benzophenone-3 (Oxybenzone) (CAS 131-57-7) is a cosmetic cosmetic ingredient functioning as UV Filter, Photostabilizer. NOAEL 67.9 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 6% (sunscreen); 0.5% (non-UV-filter use). Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 131-57-7 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Benzophenone-3 (Oxybenzone).
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Benzophenone-3 (Oxybenzone). NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 544 mg/kg bw/day | oral | mouse | Subchronic | COSMOS_DB |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =67.9 mg/kg bw/d | oral | - | NOAEL study | SCCS_vision_codex |
Pre-calculated NOAEL → SED → MoS audit trail for Benzophenone-3 (Oxybenzone) across SCCS product categories, with measured dermal absorption where available.
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LD50 | >16000 mg/kg | Rabbit | dermal | acute | ECHA IUCLID |
| LD50 | >12800 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =11600 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | >1600 mg/kg | Mouse | injection | - | ECHA IUCLID |
| NOAEL | >10000 ppm | Rat | oral | short-term | ECHA IUCLID |
| NOAEL | >789 mg/kg-day | Rat | oral | short-term | ECHA IUCLID |
| NOAEL | =600 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =393 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =429 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =4925 mg/kg-day | Mouse | oral | subchronic | ECHA IUCLID |
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: CosmEur database; DPRA: Cosmetics Europe; KS: Cosmetics Europe; hCLAT: Cosmetics Europe
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
Source list: II
agonist (ER); antagonist (AR, TR)
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| EC50_ER | ERα | 19.5 µM | agonist |
| IC50_AR | AR | 4.98 µM | antagonist |
| dermal_RF | skin | 0.01 mg/cm² (0.5% of applied dose) mg/cm² | - |
| dermal_RF_16h | skin | 1.0 ± 0.4 µg/cm² | - |
| Cell proliferation | ER | EC50/IC50: ~2 uM (EC50); LOEC: ~0.3 uM; NOEC: 0.1 uM mixed | agonist |
| ERE-driven luciferase induction | ERa | EC50/IC50: EC50 not determinable (partial plateau at 1 uM); LOEC: 1 uM; NOEC: 0.1 uM mixed | weak agonist |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| JP | restricted | Wash-away: No limit | Leave-on: 5.0% | Mucosa: 5.0% | Wash-away: No limit | Leave-on: 5.0% | Mucosa: 5.0% |
| CN | permitted_uv_filter | 10 | All cosmetics |
| IN | permitted_uv_filter | 10.0 | sunscreen and other cosmetic products |
| AU | restricted | - | sunscreens (therapeutic) |
| GCC | restricted | 6.0 | All cosmetics |
| UK | restricted | - | - |
| ID | permitted_uv_filter | 10% (current ASEAN-wide); Vietnam 2026 new limits: 6% facial/hand/lip; 2.2% body; 0.5% other; Indonesia reducing | - |
| ID | restricted | Reducing from 10% (exact new limit TBC; Indonesia aligning with EU) | Sunscreen products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 8.0 | In vitro — Franz diffusion cells | - | SCCS/1223/09 (2013) (2013) |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Sunscreen | 2–6 | 10 | CIR/FDA OTC |
1 property record from structured ingredient metadata.
Expert safety assessment and concern-level summary for Benzophenone-3 (Oxybenzone).
Public NOAEL study rows linked to Benzophenone-3 (Oxybenzone) by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg bw/d, mg/kg/ day
| Absorption % | Method | Vehicle |
|---|---|---|
| 8.0 | In vitro — Franz diffusion cells | Sunscreen o/w / w/o emulsion |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Benzophenone-3 (Oxybenzone) has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Benzophenone-3 (Oxybenzone) EU regulatory status: restricted. Maximum allowed concentration: 6% (sunscreen); 0.5% (non-UV-filter use). This is based on EU Regulation 1223/2009 and its amendments.
Benzophenone-3 (Oxybenzone) functions as: UV Filter, Photostabilizer. It is classified as a cosmetic ingredient in our database. CAS number: 131-57-7.
The NOAEL (No Observed Adverse Effect Level) for Benzophenone-3 (Oxybenzone) is 544 mg/kg bw/day based on a Subchronic study via oral route in mouse. A total of 10 study endpoints are available. Source: COSMOS_DB.
Benzophenone-3 (Oxybenzone) also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Benzophenone-3 (Oxybenzone) compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Benzophenone-3 (Oxybenzone) in your formulation.